In this issue of the Journal, we publish three Original Articles,1,2,3two Perspective articles,4,5 two editorials,6,7 a letter tothe editor,8 and an audio interview9 on the subject of humanpapillomavirus (HPV). We bring together this unique body ofinformation in response to the enormity of the health problemsthat stem from HPV and the broad interest that has been kindledby the possibility of preventing HPV-related cervical cancerand other anogenital conditions through vaccination.
The HPV vaccine is the first vaccine explicitly designed toprevent cancer induced by a virus. (The hepatitis B vaccinewas not primarily designed to . . . [Full Text of this Article]
Rothman, S. M., Rothman, D. J.
(2009). Marketing HPV Vaccine: Implications for Adolescent Health and Medical Professionalism. JAMA
302: 781-786
[Abstract][Full Text]
Hutchinson, D. J., Klein, K. C.
(2008). Human papillomavirus disease and vaccines. Am J Health Syst Pharm
65: 2105-2112
[Abstract][Full Text]
Haug, C. J.
(2008). Human Papillomavirus Vaccination -- Reasons for Caution. NEJM
359: 861-862
[Full Text]
Porta, M, Gonzalez, B, Marquez, S, Artazcoz, L
(2008). Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?. J. Epidemiol. Community Health
62: 667-667
[Full Text]
Leon, R.
(2008). Ladies first: Should boys be vaccinated against HPV?. cfp
54: 967-968
[Full Text]
Leon, R.
(2008). Les femmes d'abord: Faudrait-il vacciner les garcons contre le VPH?. cfp
54: 972-973
[Full Text]
Raffle, A. E
(2007). Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ
335: 375-377
[Full Text]